VetSheet

European Adder Antivenom

Equine-derived F(ab')2-antivenin (Vipera berus)

Antidote / ImmunoglobulinIVDogsCats

Also known as: European Adder Antivenom ยท Vipera berus antivenom ยท Adder antivenin ยท Viper antivenom

Reviewed by the VetSheet Veterinary TeamUpdated Apr 5, 2026Evidence-based veterinary reference

10 ml per animal slow i.v. (regardless of size). Consider giving 0.5 ml i.v. first and then wait 20 min to test for anaphylaxis.IVยท Single doseยท Once
10 ml โ€” Fixed dose per animal (not weight-scaled)

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Dosing by species

๐ŸŒŽ NA โ€” North America๐ŸŒ EU โ€” Europe

Dogs

IndicationDoseRouteFrequencyDurationRegion
Adder bite envenomation10 ml per animal slow i.v. (regardless of size). Consider giving 0.5 ml i.v. first and then wait 20 min to test for anaphylaxis.IVSingle doseOnce๐ŸŒ EU
  • Adder bite envenomation: Administer slowly. Dose is per animal, not weight-dependent, as the venom load is independent of the victim's size.

Cats

IndicationDoseRouteFrequencyDurationRegion
Adder bite envenomation10 ml per animal slow i.v. (regardless of size). Consider giving 0.5 ml i.v. first and then wait 20 min to test for anaphylaxis.IVSingle doseOnce๐ŸŒ EU
  • Adder bite envenomation: Administer slowly. Dose is per animal, not weight-dependent.

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Recording this consult? VetSheet's AI writes the drug, dose and duration straight into a structured visit note.See how VetSheet works

Overview

Specific immunoglobulin (antivenom) used in the management of snake bites by the European Adder (Vipera berus).

โ€‹Clinical Warning:โ€‹ The value of antivenom decreases with time following the bite. Benefits to local swelling are limited to administration within 24 hours post-bite; however, benefits towards systemic signs, when present, continue even with administration >24 hours post-bite.

โ€‹Clinical Pearl:โ€‹ There are no published studies conclusively supporting improved recovery time in small animals, but it remains the definitive treatment for severe envenomation. This antivenom is unlikely to work for other snake bites, and specialist help should be urgently sought for such bites. Urgent provision in the UK may be possible via the VPIS ToxBox service.

Mechanism of action

Contains specific immunoglobulins (typically equine-derived F(ab')2 fragments) raised against Vipera berus venom. These antibodies directly bind to and neutralize the circulating venom toxins โ†’ preventing further tissue damage, coagulopathy, and systemic toxic effects.

Safety & warnings

Contraindications

  • No specific contraindications available, but use with extreme caution in animals with known hypersensitivity to equine proteins.

Adverse effects

  • Anaphylactic reactions (can be severe)
  • Facial swelling (unrelated to the snake bite itself)
  • Profound panting
  • Unproductive cough

Precautions

โ€‹Anaphylaxis Risk:โ€‹ Equine-derived antivenoms carry a significant risk of hypersensitivity/anaphylaxis. It is strongly recommended to administer a small test dose (e.g., 0.5 ml IV) and observe for 20 minutes before administering the full dose.

  • โ€‹Supply & Import:โ€‹ In the UK, current approved suppliers can be found on the VMD website. A special dispensation from the VMD can enable supply, purchase, and use prior to STC approval in urgent cases.

Monitoring

  • Signs of anaphylaxis during and immediately after administration (panting, facial swelling, hypotension, collapse)
  • Progression or resolution of local swelling
  • Systemic signs of envenomation (coagulation parameters, cardiovascular status, renal function)

Pharmacokinetics

Half-life

DogsUnknownCatsUnknown

Absorption

Administered intravenously for immediate systemic availability.

Distribution

Distributes through extracellular fluid to bind circulating venom.

Metabolism

Degraded by the reticuloendothelial system like other immunoglobulins.

Elimination

Cleared via normal protein degradation pathways.

Overdose

No specific information available. The primary risk with large volumes of equine-derived serum is volume overload and an increased risk of hypersensitivity reactions (serum sickness).

Available products

Formulations

  • Injectable: 10 ml vial for injection (100 mg/ml)

Veterinary

  • 10 ml vial for injection (100 mg/ml)

Regulatory status

European Unionโœ— Not approvedPrescription onlyEMA
๐Ÿ• Dogs๐Ÿˆ Cats

Availability and specific approvals vary by member state.

United Kingdomโœ— Not approvedPrescription onlyVMD
๐Ÿ• Dogs๐Ÿˆ Cats

Special dispensation from the VMD can enable supply, purchase, and use prior to STC approval in urgent cases. Urgent provision may also be possible via the VPIS ToxBox service.

No regulatory data for: ๐Ÿ‡บ๐Ÿ‡ธ US ยท ๐Ÿ‡ญ๐Ÿ‡ฐ HK ยท ๐Ÿ‡น๐Ÿ‡ผ TW ยท ๐Ÿ‡ฏ๐Ÿ‡ต JP ยท ๐Ÿ‡ฐ๐Ÿ‡ท KR ยท ๐Ÿ‡ฆ๐Ÿ‡บ AU

Storage & stability

Store according to manufacturer instructions, typically refrigerated (2ยฐC to 8ยฐC). Do not freeze.

Client information

If your pet is bitten by a snake, keep them as calm and still as possible and seek emergency veterinary care immediately. Do not attempt to suck out the venom or apply a tourniquet.

Antivenom is the most effective treatment for severe bites, but it carries a risk of allergic reactions. Your vet will monitor your pet closely during administration. Recovery can take several days, and strict rest is essential.

VetSheet drug reference is intended for licensed veterinary professionals as a clinical decision-support aid, not a substitute for professional judgement or the manufacturerโ€™s current label.